The population attributable fraction as a measure of the impact of warfarin pharmacogenetic testing
10.2217/pgs.12.104
Saved in:
Main Authors: | Chan, S.L., Suo, C., Chia, K.S., Teo, Y.Y. |
---|---|
Other Authors: | SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/109073 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Clinical Applications of Pharmacogenomics of Warfarin
by: CHAN SZE LING
Published: (2013) -
Pharmacogenetics of Warfarin Should we test?
by: Pantep Angchaisuksiri, et al.
Published: (2022) -
Willingness-to-pay and preferences for warfarin pharmacogenetic testing in Chinese warfarin patients and the Chinese general public
by: Chan, S.L., et al.
Published: (2014) -
Translational aspects of genetic factors in the prediction of drug response variability: A case study of warfarin pharmacogenomics in a multi-ethnic cohort from Asia
by: Chan, S.L., et al.
Published: (2014) -
Exon sequencing and association analysis of EPHX1 genetic variants with maintenance warfarin dose in a multiethnic Asian population
by: Chan, S.L., et al.
Published: (2014)